COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2023

Jan 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2023-01-09

Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-09	Common Stock	S	10424	$27.08	Disposed	110208	Direct
2023-01-09	Common Stock	S	7341	$27.83	Disposed	102867	Direct
2023-01-09	Common Stock	S	69	$28.58	Disposed	102798	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022.

F2: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.49 to $27.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

F3: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.49 to $28.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).